Fig. 3
Adjusted cumulative incidence function (CIF) of breast cancer-specific mortality (BCSM) in HR + /HER2 −, HER2 + , and HR −/HER2 − locoregional breast cancer patients at specified TTS points (30, 60, 90, and 120 days) in a SEER-Medicare cohort
Fig. 3 | Breast Cancer Research